Safety alertSource: FDA Drug Enforcement Reports

Class I recall: Liebel-Flarsheim Company LLC: Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically

The FDA has classified a Class I recall for Liebel-Flarsheim Company LLC's Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, in 500 mL multiple-dose vials (NDC 0019-1333-65). The recall was initiated due to the presence of particulate matter identified as polyethylene and other plastic materials, stainless steel, and glass. Class I recalls are used by the FDA for situations in which use of the affected product could cause serious injury or death.”

Most relevant for: patients undergoing cardiac imaging procedures requiring intravenous contrast injection

Read the original at FDA Drug Enforcement Reports

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.

Specialties

More internal medicine updates

Get updates for your specialty